Log In
BCIQ
Print this Print this
 

apabetalone (RVX000222) (RVX-208)

  Manage Alerts
Collapse Summary General Information
Company Resverlogix Corp.
DescriptionInhibitor of the BET family of bromodomain-containing proteins, including bromodomain containing 4 (BRD4)
Molecular Target Bromodomain containing 4 (BRD4) ; Apolipoprotein A-1 (APOA1)
Mechanism of ActionCholesterol removal
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$428.7M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/27/2015

$428.7M

0

Undisclosed

Get a free BioCentury trial today